ClinicalTrialsFinder

MSI-H Solid Malignant Tumor Clinical Trials in Barcelona

1 recruitingBarcelona, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Beta-only IL-2 ImmunoTherapY Study

Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692